Pharmaceutical

MorphoSys gets grant for novel compounds for treating diseases associated with methyl modifying enzymes

Discover a groundbreaking patent by MorphoSys AG for novel compounds targeting methyl modifying enzymes in cancer treatment. Learn about Formula (I) compounds and their potential impact on various types of cancer.

Apr 11, 2024 - 00:00
Discover a groundbreaking patent by MorphoSys AG for novel compounds targeting methyl modifying enzymes in cancer treatment. Learn about Formula (I) compounds and their potential impact on various types of cancer.
Read the original article

Tags:

Previous Article

Acceleron Pharma gets grant for treatment of spinal muscular atrophy using ALK4:...

Next Article

ADMA Biologics gets grant for treatment of upper respiratory tract infection wit...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AGC and Asahi partner for clinical drug production in Seattle

AGC and Asahi partner for clinical drug production in S...

Aug 16, 2023

Panbela Therapeutics and Johns Hopkins to expand ivospemin development

Panbela Therapeutics and Johns Hopkins to expand ivospe...

Apr 4, 2023

STAT+: The new NIH director is walking a tightrope on Biden’s drug pricing vision

STAT+: The new NIH director is walking a tightrope on B...

Jan 16, 2024